National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Access to Care (4)
- Adverse Drug Events (ADE) (7)
- Adverse Events (7)
- Ambulatory Care and Surgery (1)
- Arthritis (2)
- Asthma (1)
- Autism (1)
- Behavioral Health (1)
- Cancer (3)
- Cancer: Breast Cancer (1)
- Cancer: Cervical Cancer (1)
- Cancer: Lung Cancer (1)
- Caregiving (4)
- Children/Adolescents (59)
- Chronic Conditions (1)
- Clinical Decision Support (CDS) (2)
- Clinician-Patient Communication (5)
- Communication (6)
- Community-Based Practice (1)
- Comparative Effectiveness (3)
- COVID-19 (24)
- Dialysis (1)
- Digestive Disease and Health (1)
- Disparities (5)
- Ear Infections (1)
- Education (2)
- Education: Patient and Caregiver (8)
- Elderly (2)
- Electronic Health Records (EHRs) (1)
- Emergency Medical Services (EMS) (1)
- Emergency Preparedness (1)
- Evidence-Based Practice (3)
- Genetics (1)
- Guidelines (3)
- Healthcare Cost and Utilization Project (HCUP) (8)
- Healthcare Costs (30)
- Healthcare Delivery (3)
- Healthcare Utilization (5)
- Health Information Exchange (HIE) (1)
- Health Information Technology (HIT) (12)
- Health Insurance (2)
- Health Literacy (1)
- Health Promotion (4)
- Health Services Research (HSR) (4)
- Health Status (1)
- Health Systems (1)
- Hepatitis (2)
- Hospital Discharge (1)
- Hospitalization (11)
- Human Immunodeficiency Virus (HIV) (5)
- Infectious Diseases (31)
- Influenza (26)
- Kidney Disease and Health (2)
- Labor and Delivery (1)
- Long-Term Care (1)
- Low-Income (3)
- Medicaid (1)
- Medicare (1)
- Medication (9)
- Medication: Safety (1)
- Mortality (2)
- Newborns/Infants (6)
- Nursing Homes (3)
- Outcomes (1)
- Patient-Centered Outcomes Research (2)
- Patient Adherence/Compliance (3)
- Patient and Family Engagement (1)
- Patient Safety (7)
- Payment (1)
- Pneumonia (7)
- Policy (5)
- Practice Patterns (3)
- Pregnancy (4)
- Prevention (26)
- Primary Care (2)
- Provider (2)
- Provider: Clinician (1)
- Provider: Health Personnel (1)
- Provider: Pharmacist (7)
- Provider: Physician (2)
- Public Health (20)
- Public Reporting (1)
- Quality Improvement (1)
- Racial and Ethnic Minorities (8)
- Registries (2)
- Research Methodologies (2)
- Respiratory Conditions (5)
- Risk (4)
- Rural/Inner-City Residents (1)
- Rural Health (1)
- Screening (2)
- Sex Factors (1)
- Sexual Health (12)
- Shared Decision Making (7)
- Skin Conditions (2)
- Social Determinants of Health (3)
- Social Media (6)
- Substance Abuse (1)
- Surgery (3)
- System Design (1)
- Teams (1)
- Telehealth (1)
- Transplantation (10)
- Urban Health (2)
- (-) Vaccination (162)
- Vulnerable Populations (5)
- Web-Based (2)
- Women (6)
- Young Adults (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
26 to 50 of 162 Research Studies DisplayedOster NV, Williams EC, Unger JM
A risk prediction model to identify newborns at risk for missing early childhood vaccinations.
Approximately 30% of US children aged 24 months have not received all recommended vaccines. This retrospective cohort study aimed to develop a prediction model to identify newborns at high risk for missing early childhood vaccines. The investigators concluded that their prediction model using information readily available in birth hospitalization records consistently identified newborns at high risk for undervaccination.
AHRQ-funded; HS025470.
Citation: Oster NV, Williams EC, Unger JM .
A risk prediction model to identify newborns at risk for missing early childhood vaccinations.
J Pediatric Infect Dis Soc 2021 Dec 31;10(12):1080-86. doi: 10.1093/jpids/piab073..
Keywords: Newborns/Infants, Vaccination, Risk
Feldman AG, O'Leary ST, Danziger-Isakov L
The risk of resurgence in vaccine-preventable infections due to coronavirus disease 2019-related gaps in immunization.
This paper discusses the decline in immunization delivery during the COVID-19 pandemic. The global community is at risk for a resurgence in vaccine-preventable infections including measles, pertussis, and polio. Outbreaks in the United States are likely to occur when social distancing stops and children return to school. Partnerships between healthcare providers, community leaders, and local, state, regional, and national public health departments are needed to reassure families that vaccine delivery during COVID-19 is safe as well as to identify and catch up those children who are under-immunized.
AHRQ-funded; HS026510.
Citation: Feldman AG, O'Leary ST, Danziger-Isakov L .
The risk of resurgence in vaccine-preventable infections due to coronavirus disease 2019-related gaps in immunization.
Clin Infect Dis 2021 Nov 16;73(10):1920-23. doi: 10.1093/cid/ciab127..
Keywords: COVID-19, Children/Adolescents, Vaccination, Infectious Diseases
Cox SN, Wedlock PT, Pallas SW
A systems map of the economic considerations for vaccination: application to hard-to-reach populations.
The authors developed a systems map of the mechanisms involved in vaccination, and associated costs and benefits, focused at the service delivery level, in order to identify the mechanisms that may be different for hard-to-reach populations. They concluded that decision-makers can use this systems map to understand where steps in the vaccination process may be interrupted or weak and identify where gaps exist in the understanding of the economics of vaccination. With improved understanding of system-wide effects, their map can help decision-makers inform targeted interventions and policies to increase vaccination coverage in hard-to-reach populations.
AHRQ-funded; HS023317; HS028165.
Citation: Cox SN, Wedlock PT, Pallas SW .
A systems map of the economic considerations for vaccination: application to hard-to-reach populations.
Vaccine 2021 Nov 5;39(46):6796-804. doi: 10.1016/j.vaccine.2021.05.033..
Keywords: Vaccination, Healthcare Costs
Krantz MS, Stone CA, Rolando LA
An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history.
This retrospective cohort study examined the outcomes of screening mRNA COVID-19 vaccine risk using patient-reported anaphylactic history at a single academic hospital employee vaccination program. Although rare, m-RNA COVID-19 vaccines have been contraindicated in patients with known allergy to polyethylene glycol (PEG) 2000 present in the lipid nanoparticle carrier system of these vaccines. Health care workers and other affiliates who met criteria based on the Tennessee Department of Health COVID-19 Vaccination Plan received the first dose of Pfizer m-RNA vaccine. Out of 23,035 individuals who were screened before dose 1, 31 reported a high-risk allergy history that triggered a focused review by the Allergist On-Call. Out of those 31, only 3 were recommended not to proceed to Dose 1 and were referred to the Drug Allergy Clinic for assessment. Ultimately, all individuals were cleared to receive their first dose, and none reported an adverse reaction.
AHRQ-funded; HS026395.
Citation: Krantz MS, Stone CA, Rolando LA .
An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history.
J Allergy Clin Immunol Pract 2021 Oct;9(10):3807-10. doi: 10.1016/j.jaip.2021.07.010..
Keywords: COVID-19, Screening, Vaccination
Bartsch SM, Wedlock PT, O'Shea KJ
Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination.
The authors developed a computational model representing the United States population, COVID-19 coronavirus spread (February 2020-December 2022), and vaccination to determine the impact of increasing coverage and expediting time to achieve coverage. They concluded that their study quantified the potential value of decreasing vaccine hesitancy and increasing vaccination coverage and how this value may decrease with the time it takes to achieve coverage, emphasizing the need to reach high coverage levels as soon as possible, especially before the fall/winter.
AHRQ-funded; HS028165.
Citation: Bartsch SM, Wedlock PT, O'Shea KJ .
Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination.
J Infect Dis 2021 Sep 17;224(6):938-48. doi: 10.1093/infdis/jiab233..
Keywords: COVID-19, Vaccination, Public Health
Hofstetter AM, Opel DJ, Stockwell MS
Associations between health care professional communication practices and influenza vaccination of hospitalized children.
The objective of this study was to describe the communication of health care professionals (HCPs) with parents of hospitalized children concerning the influenza vaccine. A survey was conducted online or via telephone with English- and Spanish-speaking parents of influenza vaccine-eligible children hospitalized at a pediatric hospital after discharge. Findings showed that a parent-reported HCP conversation and recommendation were associated with influenza vaccination during hospitalization.
AHRQ-funded; HS025470.
Citation: Hofstetter AM, Opel DJ, Stockwell MS .
Associations between health care professional communication practices and influenza vaccination of hospitalized children.
Acad Pediatr 2021 Sep-Oct;21(7):1142-50. doi: 10.1016/j.acap.2021.06.014..
Keywords: Children/Adolescents, Influenza, Vaccination, Communication, Health Promotion, Clinician-Patient Communication
Dutta S, McEvoy DS, Stump T
Clinical decision support reduces unnecessary tetanus vaccinations in the emergency department.
The authors implemented a clinical decision support alert in the electronic health record that warned providers when ordering a tetanus vaccine if a prior one had been given within 10 years and studied its efficacy to reduce potentially unnecessary vaccines in the ED. They found that a clinical decision support alert that warns ED clinicians that a patient may have an up-to-date tetanus vaccination status reduced potentially unnecessary vaccinations.
AHRQ-funded; HS027170.
Citation: Dutta S, McEvoy DS, Stump T .
Clinical decision support reduces unnecessary tetanus vaccinations in the emergency department.
Ann Emerg Med 2021 Sep;78(3):370-80. doi: 10.1016/j.annemergmed.2021.02.021..
Keywords: Clinical Decision Support (CDS), Shared Decision Making, Vaccination, Health Information Technology (HIT)
Holaday LW, Balasuriya L, Roy B
Medicare beneficiaries' plans for the COVID-19 vaccine in Fall 2020, and why some planned to decline.
This study uses data from a survey of Medicare beneficiaries conducted in the fall of 2020 before the COVID-19 vaccine was approved to try and predict COVID-19 vaccine acceptance and decline rates. A cross-sectional analysis using the Medicare Current Beneficiary Survey (MCBS) Fall COVID-19 Supplement was used to conduct telephone interviews administered by NORC at the University of Chicago. The analysis included 8,455 community-dwelling Medicare beneficiaries, representative of 50.2 million people. Overall, 58.7% said they would get the vaccine, 15.3% said they would not, and 26.1% were unsure. Least likely to say they would get a vaccine were beneficiaries under 65 years old (48.8%), Black beneficiaries (36.2%) and Hispanic beneficiaries (50.5%). Reasons given for not planning to get vaccinated included 1) the vaccine could have side effects or is not safe (42.4%), 2) do not trust what the government says about the vaccine (42.4%), 3) do not think the vaccine would prevent COVID-19 (11.%), and 4) do not like vaccines or needles (8.2%). Black and Hispanic beneficiaries were more likely to say they were declining because they don’t trust the government than White beneficiaries. Younger beneficiaries were more likely to say the vaccine could cause COVID-19, and only 2% of respondents said they would decline the vaccine because COVID-19 is not serious. The latter group was disproportionately male (77.5%) and White (94.5%).
AHRQ-funded; HS022882; HS025164.
Citation: Holaday LW, Balasuriya L, Roy B .
Medicare beneficiaries' plans for the COVID-19 vaccine in Fall 2020, and why some planned to decline.
J Am Geriatr Soc 2021 Sep;69(9):2434-37. doi: 10.1111/jgs.17285..
Keywords: COVID-19, Vaccination, Medicare
Khorasani SB, Koutoujian PJ, Zubiago J
COVID-19 vaccine interest among corrections officers and people who are incarcerated at Middlesex County jail, Massachusetts.
The Middlesex [Massachusetts] Sheriff’s Office developed and distributed two self-response surveys to assess COVID-19 vaccine willingness among people incarcerated in the jail and among people who work at the jail. The goal of this study was to characterize vaccine willingness in these two populations at the Middlesex House of Correction and Jail. Findings showed that 59% of people incarcerated in jail did not want the COVID-19 vaccine, while 82% of jail staff were interested in receiving the vaccine. Among people who were incarcerated, those who identified as Black had significantly decreased odds of wanting the vaccine compared to those who identified as white. Race was not significantly associated with vaccine willingness among jail employees when adjusting for role and gender.
AHRQ-funded; HS026008.
Citation: Khorasani SB, Koutoujian PJ, Zubiago J .
COVID-19 vaccine interest among corrections officers and people who are incarcerated at Middlesex County jail, Massachusetts.
J Urban Health 2021 Aug;98(4):459-63. doi: 10.1007/s11524-021-00545-y..
Keywords: COVID-19, Vaccination, Vulnerable Populations
Caballero ML, Krantz MS, Quirce S
Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions.
In this paper, the authors provided a review of the evidence-based literature outlining epidemiology and mechanisms of excipient reactions and provided strategies for heightened recognition and allergy testing.
AHRQ-funded; HS026395.
Citation: Caballero ML, Krantz MS, Quirce S .
Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions.
J Allergy Clin Immunol Pract 2021 Aug;9(8):2968-82. doi: 10.1016/j.jaip.2021.03.002..
Keywords: Adverse Drug Events (ADE), Adverse Events, Medication, Medication: Safety, Vaccination, Patient Safety
Hofstetter AM, Opel DJ, Stockwell MS
Influenza-related knowledge, beliefs, and experiences among caregivers of hospitalized children.
Caregivers frequently decline influenza vaccine for their hospitalized child. In this study, the investigators aimed to examine factors impacting their influenza vaccine decision-making. The investigators conducted a cross-sectional survey study of English- and Spanish-speaking caregivers of children hospitalized at a tertiary care pediatric hospital between November 2017 and April 2018.They identified key factors impacting influenza vaccine decision-making among caregivers of hospitalized children, a critical step to improving uptake in this population.
AHRQ-funded; HS025470.
Citation: Hofstetter AM, Opel DJ, Stockwell MS .
Influenza-related knowledge, beliefs, and experiences among caregivers of hospitalized children.
Hosp Pediatr 2021 Aug;11(8):815-32. doi: 10.1542/hpeds.2020-003459..
Keywords: Children/Adolescents, Caregiving, Influenza, Vaccination
Orenstein EW, ElSayed-Ali O, Kandaswamy S
Evaluation of a clinical decision support strategy to increase seasonal influenza vaccination among hospitalized children before inpatient discharge.
The authors’ goal was to design and evaluate a clinical decision support (CDS) strategy to increase the proportion of eligible hospitalized children who receive a seasonal influenza vaccine prior to inpatient discharge. They found that a user-centered CDS may be associated with significantly improved influenza vaccination rates among hospitalized children.
AHRQ-funded; HS027689.
Citation: Orenstein EW, ElSayed-Ali O, Kandaswamy S .
Evaluation of a clinical decision support strategy to increase seasonal influenza vaccination among hospitalized children before inpatient discharge.
JAMA Netw Open 2021 Jul;4(7):e2117809. doi: 10.1001/jamanetworkopen.2021.17809..
Keywords: Children/Adolescents, Influenza, Vaccination, Clinical Decision Support (CDS), Health Information Technology (HIT), Hospital Discharge
Glenn BA, Nonzee NJ, Tieu L
Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
This study looked at the barriers to human papillomavirus (HPV) vaccination among young adults receiving care at the student health center of a large public university. The authors conducted semi-structured interviews (n=27) and four focus groups with undergraduate and graduate students (n=18) and semi-structured interviews with 6 health care providers. The interviews and focus groups explored perceived risk of HPV infection, benefits of the HPV vaccine, and motivations for and barriers to HPV vaccination. Many students cited their parents’ views and recommendations from their medical providers as influential on their decision-making process. Cervical cancer prevention was considered the main benefit of the HPV vaccine and sexual activity was a risk factor for HPV infection. Students often lacked knowledge about the vaccine’s benefit for males. Safety and side effects of the vaccine perceived as new were also cited. Providers’ vaccine recommendations were impacted by health system factors including clinical infrastructure, office visit priorities, and processes for recommending and documentation vaccination. Providers suggested various promotion strategies including improving the timing and messaging of outreach efforts on campus and bolstering clinical infrastructure.
AHRQ-funded; HS000046.
Citation: Glenn BA, Nonzee NJ, Tieu L .
Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
Vaccine 2021 Jun 8;39(25):3435-44. doi: 10.1016/j.vaccine.2021.04.019..
Keywords: Young Adults, Sexual Health, Infectious Diseases, Vaccination, Prevention, Cancer: Cervical Cancer, Cancer, Women
Hofstetter AM, Schaffer S
Childhood and adolescent vaccination in alternative settings.
This article reviews the unique advantages, challenges, and experiences regarding vaccine delivery in alternative settings, such as schools, emergency rooms, hospitals, and pharmacies. It describes the key components that each setting must possess as well as other important factors to consider when assessing the ability of each to deliver vaccines to the children and adolescents they serve. It is important to emphasize that these settings should not replace the medical home as the primary location for vaccination, but rather serve as a critical safety net for high-risk individuals and communities and in situations where access to traditional locations may be limited, such as during the COVID-19 pandemic.
AHRQ-funded; HS025470.
Citation: Hofstetter AM, Schaffer S .
Childhood and adolescent vaccination in alternative settings.
Acad Pediatr 2021 May-Jun;21(4s):S50-s56. doi: 10.1016/j.acap.2021.02.001..
Keywords: Children/Adolescents, Vaccination, Healthcare Delivery, Public Health
Bartsch SM, O'Shea KJ, Wedlock PT
The benefits of vaccinating with the first available COVID-19 coronavirus vaccine.
This study’s objective was to determine quantitatively the benefits of early vaccination for COVID-19 even if later on in the pandemic a latter vaccine has substantially higher efficacy. The team developed this model in 2020 before vaccinations became available. For example if a vaccine with 50% efficacy becomes available when 10% of the population has already been infected, waiting until 40% of the population are infected for a vaccine with 80% efficacy results in 15.6 million additional cases and 1.5 million additional hospitalizations, costing $20.6 billion more in direct medical costs and $12.4 billion more in productivity losses.
AHRQ-funded; HS028165.
Citation: Bartsch SM, O'Shea KJ, Wedlock PT .
The benefits of vaccinating with the first available COVID-19 coronavirus vaccine.
Am J Prev Med 2021 May;60(5):605-13. doi: 10.1016/j.amepre.2021.01.001..
Keywords: COVID-19, Vaccination, Healthcare Costs, Prevention, Infectious Diseases
Teixeira da Silva D, Biello K, Lin WY
COVID-19 vaccine acceptance among an online sample of sexual and gender minority men and transgender women.
Sexual and gender minority (SGM) populations are particularly vulnerable to poor COVID-19 outcomes and are more likely to experience stigma and medical mistrust that may impact COVID-19 vaccine acceptance. This study examined the prevalence of COVID testing and diagnosis and assessed COVID-19 vaccine acceptance among a large sample of SGM. The investigators found that black participants were significantly less likely to accept a COVID-19 vaccine, and Asian participants were significantly more likely to accept a vaccine, compared to White peers.
AHRQ-funded; HS0226116.
Citation: Teixeira da Silva D, Biello K, Lin WY .
COVID-19 vaccine acceptance among an online sample of sexual and gender minority men and transgender women.
Vaccines 2021 Mar;9(3). doi: 10.3390/vaccines9030204..
Keywords: Vaccination, COVID-19, Public Health, Racial and Ethnic Minorities, Vulnerable Populations
Bartsch SM, O'Shea KJ, Wedlock PT
Potential clinical and economic value of norovirus vaccination in the community setting.
This paper examined the potential clinical and economic value of norovirus vaccination in a community setting using a transmission, clinical, and economics computation simulation model representing different U.S. population segments. The simulation looked at the impact of vaccinating children <5 years and older adults aged 65 and older. Compared with no vaccine, vaccinating preschool-aged children averted 8-7% of symptomatic norovirus cases in a community and vaccinating older adults averted 2-29% of symptomatic cases. Vaccination with a 25% vaccine efficacy was cost effective when vaccinations cost ≤$445 and cost saving at ≤$370 when vaccinating preschool-aged children and ≤$42 and ≤$30, respectively for older adults. With 50% efficacy, vaccination was cost effective when it cost ≤$1,190 and cost saving at ≤$930 when vaccinating preschool-aged children and ≤$110 and ≤$64, respectively, for older adults. At 75% vaccine efficacy the cost thresholds increased to ≤$1,600 and ≤$1,300 for preschool-aged children and ≤$165 and ≤$100 for older adults.
AHRQ-funded; HS023317.
Citation: Bartsch SM, O'Shea KJ, Wedlock PT .
Potential clinical and economic value of norovirus vaccination in the community setting.
Am J Prev Med 2021 Mar;60(3):360-68. doi: 10.1016/j.amepre.2020.10.022..
Keywords: Infectious Diseases, Vaccination, Healthcare Costs
Fisher KA, Bloomstone SJ, Walder J
Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults.
The authors assessed the intent to be vaccinated against COVID-19 among a representative sample of adults in the United States and identified predictors of and reasons for vaccine hesitancy. They found that approximately 3 in 10 adults were not sure they would accept vaccination and 1 in 10 did not intend to be vaccinated against COVID-19. They recommended targeted and multipronged efforts to increase acceptance of a COVID-19 vaccine.
AHRQ-funded; HS024596.
Citation: Fisher KA, Bloomstone SJ, Walder J .
Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults.
Ann Intern Med 2020 Dec 15;173(12):964-73. doi: 10.7326/m20-3569..
Keywords: COVID-19, Vaccination, Public Health, Patient Adherence/Compliance
Chabra S, Hofstetter AM
Timely hepatitis B birth dose receipt for newborns: within 24 hours.
In this paper, the authors discuss the importance of timely administration of the hepatitis B birth dose to achieve the national goal of zero perinatal hepatitis B transmission in the near future. They state that the necessity of capturing vaccination opportunities in diverse health care settings is clearly evident during the coronavirus pandemic.
AHRQ-funded; HS025470.
Citation: Chabra S, Hofstetter AM .
Timely hepatitis B birth dose receipt for newborns: within 24 hours.
Hosp Pediatr 2020 Dec;10(12):e18-e20. doi: 10.1542/hpeds.2020-001255..
Keywords: Newborns/Infants, Hepatitis, Vaccination
Kemme S, Sundaram SS, Curtis DJ
A community divided: post-transplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers.
The goal of this study was to assess current post-transplant live vaccine practices at individual pediatric liver transplant centers following the updated AST guidelines. Using email surveys with a 93% response rate, findings showed that only 29% of centers offered live vaccines post-transplant, with each center using different eligibility criteria for live vaccines. The main reasons for a center not offering post-transplant live vaccines were safety concerns and inability to reach group consensus.
AHRQ-funded; HS026510.
Citation: Kemme S, Sundaram SS, Curtis DJ .
A community divided: post-transplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers.
Pediatr Transplant 2020 Aug 26:e13804. doi: 10.1111/petr.13804..
Keywords: Children/Adolescents, Transplantation, Surgery, Vaccination, Practice Patterns
Bartsch SM, O'Shea KJ, Ferguson MC
Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention.
This study examined the needed efficacy and coverage of a COVID-19 vaccine to prevent or stop the pandemic. Simulation experiments were conducted at 60-80% efficacy rates. At 60% efficacy, vaccination coverage needs to be 100%. If the coverage rate is reduced to 75%, the efficacy needs to be 70% and up to 80% when coverage drops to 60%. These findings show that the vaccine needs to have at least an efficacy rate of 70% to prevent an epidemic and at least 80% to extinguish an epidemic without any other measures such as social distancing.
AHRQ-funded; HS023317.
Citation: Bartsch SM, O'Shea KJ, Ferguson MC .
Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention.
Am J Prev Med 2020 Oct;59(4):493-503. doi: 10.1016/j.amepre.2020.06.011..
Keywords: Vaccination, COVID-19, Public Health, Prevention, Evidence-Based Practice, Infectious Diseases
Bartsch SM, Mitgang EA, Geller G
What if the influenza vaccine did not offer such variable protection?
This study looked at the impact of reducing the variability in responses to the influenza vaccine across the population. Protection from the vaccine can vary significantly from person to person due to differences in immune systems, body types, and other factors. The authors compared the projected cases, direct medical costs, and productivity losses at the 30%, 50%, and 70% efficacy rates.
AHRQ-funded; HS023317.
Citation: Bartsch SM, Mitgang EA, Geller G .
What if the influenza vaccine did not offer such variable protection?
J Infect Dis 2020 Sep 1;222(7):1138-44. doi: 10.1093/infdis/jiaa240..
Keywords: Influenza, Vaccination, Respiratory Conditions, Public Health
Bartsch SM, Stokes-Cawley OJ, Buekens P
The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Currently, there are no solutions to prevent congenital transmission of Chagas disease during pregnancy, which affects 1-40% of pregnant women in Latin America and is associated with a 5% transmission risk. In this study the investigators sought to determine the economic value of therapeutic vaccines to prevent congenital transmission. The investigators delineated the thresholds at which therapeutic vaccination of Chagas-positive pregnant women would be cost-effective and cost-saving, providing economic guidance for decision-makers to consider when developing and bringing such a vaccine to market.
AHRQ-funded; HS023317.
Citation: Bartsch SM, Stokes-Cawley OJ, Buekens P .
The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Vaccine 2020 Apr 3;38(16):3261-70. doi: 10.1016/j.vaccine.2020.02.078..
Keywords: Vaccination, Healthcare Costs, Pregnancy, Women
Bartsch SM, Asti L, Stokes-Cawley OJ
The potential economic value of a Zika vaccine for a woman of childbearing age.
The authors mapped the Zika vaccine and vaccination characteristic thresholds at which vaccination becomes cost effective, highly cost effective, and cost saving. They developed a Markov model to simulate a woman of childbearing age to follow the potential risk and clinical course of a Zika infection. They found that, in some cases, the vaccine was cost effective when the risk was as low as 0.015%, the cost was as high as $7,500, the efficacy was as low as 25%, and the duration of protection was 1 year. They concluded that the thresholds at which vaccination becomes cost effective and cost saving can provide targets for Zika vaccine development and implementation.
AHRQ-funded; HS023317.
Citation: Bartsch SM, Asti L, Stokes-Cawley OJ .
The potential economic value of a Zika vaccine for a woman of childbearing age.
Am J Prev Med 2020 Mar;58(3):370-77. doi: 10.1016/j.amepre.2019.10.023..
Keywords: Vaccination, Women, Infectious Diseases, Public Health, Healthcare Costs, Prevention
Butler AM, Layton JB, Dharnidharka VR
Comparative effectiveness of high-dose versus standard-dose influenza vaccine among patients receiving maintenance hemodialysis.
This study compared outcomes of routine dialysis patients who received either the standard dose vaccine (SDV) for influenza or a high-dose vaccine (HDV). Out of 22,215 influenza patient-seasons among adults 65 years and older, 97.4% received SDV and 2.6% received HDV. There did not seem to be any additional protection provided by the HDV for all-cause mortality or influenza-related outcomes.
AHRQ-funded; HS019455.
Citation: Butler AM, Layton JB, Dharnidharka VR .
Comparative effectiveness of high-dose versus standard-dose influenza vaccine among patients receiving maintenance hemodialysis.
Am J Kidney Dis 2020 Jan;75(1):72-83. doi: 10.1053/j.ajkd.2019.05.018..
Keywords: Vaccination, Influenza, Comparative Effectiveness, Dialysis, Kidney Disease and Health, Hospitalization, Outcomes